ÂÜÀòÂÒÂ×

Leila Jirmann is currently the Head of Study Coordination at emovis GmbH. Prior to this role, Leila was a Clinical Study Coordinator at the same company. Before joining emovis GmbH, Leila was a Master Student at Max Planck Institute for Infection Biology, specializing in Molecular Biology. Leila's master thesis focused on the role of cancer-related mutations in growth factor independence of gastric organoids. Leila holds a Master of Science in Molecular Life Science from Humboldt-Universität zu Berlin and a Bachelor of Science in Biowissenschaften from Goethe University Frankfurt.